Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin)

dc.contributor.author	Sadikova N.G
dc.contributor.author	Najmutdinova D. K
dc.contributor.author	Urunbayeva D. A
dc.contributor.author	Alimova S. E
dc.contributor.author	Tillaboyev Sh.Sh
dc.date.accessioned	2026-01-02T11:06:15Z
dc.date.issued	2023-11-06
dc.description.abstract	Study of the effect of SGLT-2ingibitors on kidney function in Diabetes Mellitus Type 2 patients
dc.format	application/pdf
dc.identifier.uri	https://geniusjournals.org/index.php/ejrdi/article/view/5178
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/76946
dc.language.iso	eng
dc.publisher	Genius Journals
dc.relation	https://geniusjournals.org/index.php/ejrdi/article/view/5178/4348
dc.rights	https://creativecommons.org/licenses/by-nc/4.0
dc.source	Eurasian Journal of Research, Development and Innovation; Vol. 26 (2023): EJRDI; 1-4
dc.source	2795-7616
dc.subject	SGLT-2ingibitors
dc.subject	Diabetes Mellitus
dc.title	Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin)
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: ng_2023_sglt-2_inhibitors_in_diabetic_type_2_pat.pdf
item.page.filesection.size: 231.65 KB
item.page.filesection.format: Adobe Portable Document Format